BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35411787)

  • 1. Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.
    Mejia EJ; Lin KY; Okunowo O; Iacobellis KA; Matesanz SE; Brandsema JF; Wittlieb-Weber CA; Katcoff H; Griffis H; Edelson JB
    J Am Heart Assoc; 2022 Apr; 11(8):e024722. PubMed ID: 35411787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
    Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.
    Aikawa T; Takeda A; Oyama-Manabe N; Naya M; Yamazawa H; Koyanagawa K; Ito YM; Anzai T
    Pediatr Cardiol; 2019 Feb; 40(2):384-392. PubMed ID: 30564867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity.
    Soslow JH; Hall M; Burnette WB; Hor K; Chisolm J; Spurney C; Godown J; Xu M; Slaughter JC; Markham LW
    Cardiol Young; 2019 Mar; 29(3):290-296. PubMed ID: 30683166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
    Kaspar RW; Allen HD; Montanaro F
    J Am Acad Nurse Pract; 2009 May; 21(5):241-9. PubMed ID: 19432907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.
    Mathews KD; Cunniff C; Kantamneni JR; Ciafaloni E; Miller T; Matthews D; Cwik V; Druschel C; Miller L; Meaney FJ; Sladky J; Romitti PA
    J Child Neurol; 2010 Sep; 25(9):1098-102. PubMed ID: 20817884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Cardiac Outcomes by Early Treatment with Angiotensin-Converting Enzyme Inhibitors in Becker Muscular Dystrophy.
    Stalens C; Motté L; Béhin A; Ben Yaou R; Leturcq F; Bassez G; Laforêt P; Fontaine B; Ederhy S; Masingue M; Saadi M; Louis SL; Berber N; Stojkovic T; Duboc D; Wahbi K
    J Neuromuscul Dis; 2021; 8(4):495-502. PubMed ID: 33814458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
    Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
    JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise Cardiac Magnetic Resonance Imaging in Boys With Duchenne Muscular Dystrophy Without Cardiac Disease.
    Power LC; Gusso S; Hornung TS; Jefferies C; Derraik JGB; Hofman PL; O'Grady GL
    Pediatr Neurol; 2021 Apr; 117():35-43. PubMed ID: 33662889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.
    Matesanz SE; Edelson JB; Iacobellis KA; Mejia E; Brandsema JF; Wittlieb-Weber CA; Okunowo O; Griffis H; Lin KY
    Neurol Clin Pract; 2024 Aug; 14(4):e200312. PubMed ID: 38855715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(40):1119-22. PubMed ID: 19834452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac involvement in dystrophinopathies].
    Wahbi K
    Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S37-41. PubMed ID: 26773585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION.
    Villa C; Auerbach SR; Bansal N; Birnbaum BF; Conway J; Esteso P; Gambetta K; Hall EK; Kaufman BD; Kirmani S; Lal AK; Martinez HR; Nandi D; O'Connor MJ; Parent JJ; Raucci FJ; Shih R; Shugh S; Soslow JH; Tunuguntla H; Wittlieb-Weber CA; Kinnett K; Cripe L
    Pediatr Cardiol; 2022 Jun; 43(5):977-985. PubMed ID: 35024902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy.
    O'Brien L; Varadi R; Goldstein RS; Evans RA
    Chron Respir Dis; 2014 May; 11(2):103-10. PubMed ID: 24728656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of variation in estimates of Duchenne and Becker muscular dystrophy prevalence in the United States.
    Whitehead N; Erickson SW; Cai B; McDermott S; Peay H; Howard JF; Ouyang L;
    Orphanet J Rare Dis; 2023 Mar; 18(1):65. PubMed ID: 36949506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Duchenne Muscular Dystrophy Care Considerations.
    Andrews JG; Conway K; Westfield C; Trout C; Meaney FJ; Mathews K; Ciafaloni E; Cunniff C; Fox DJ; Matthews D; Pandya S
    Pediatrics; 2018 Jul; 142(1):. PubMed ID: 29925575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.